Mapping the Progress of Alzheimer's and Parkinson's Disease (Advances in Behavioral Biology)

588 Pages·2002·12.01 MB·English

by  Yoshikuni Mizuno

MAPPING THE PROGRESS
OF ALZHEIMER’S AND
PARKINSON’S DISEASE
ADVANCES IN BEHAVIORAL BIOLOGY
EditorialBoard
Jan Bures Institute of Physiology, Prague, Czech Republic
Irwin Kopin National Institute of Mental Health, Bethesda, Maryland
Bruce McEwen Rockefeller University, New York, New York
Karl Pribram Radford University, Radford, Virginia
Jay Rosenblatt Rutgers University, Newark, New Jersey
Lawrence Weiskranz University of Oxford, Oxford, England
Recent Volumes in This Series
Volume 37 KINDLING 4
Edited by Juhn A. Wada
Volume 38A BASIC, CLINICAL, AND THERAPEUTIC ASPECTS OF ALZHEIMER’S AND
PARKINSON’S DISEASES, Volume 1
Edited by Toshiharu Nagatsu, Abraham Fisher, and Mitsuo Yoshida
Volume 38B BASIC, CLINICAL, AND THERAPEUTIC ASPECTS OF ALZHEIMER’S AND
PARKINSON’S DISEASES, Volume 2
Edited by Toshiharu Nagatsu, Abraham Fisher, and Mitsuo Yoshida
Volume 39 THE BASAL GANGLIA III
Edited by Giorgio Bernardi, Malcolm B. Carpenter, Gaetano Di Chiara, Micaela Morelli,
and Paolo Stanzione
Volume 40 TREATMENT OF DEMENTIAS: A New Generation of Progress
Edited by Edwin M. Meyer, James W. Simpkins, Jyunji Yamamoto, and Fulton T. Crews
Volume 41 THE BASAL GANGLIA IV: New Ideas and Data on Structure and Function
Edited by Gérard Percheron, John S. McKenzie, and Jean Féger
Volume 42 CALLOSAL AGENESIS: A Natural Split Brain?
Edited by Maryse Lassonde and Malcolm A. Jeeves
Volume 43 NEUROTRANSMITTERS IN THE HUMAN BRAIN
Edited by David J. Tracey, George Paxinos, and Jonathan Stone
Volume 44 ALZHEIMER’S AND PARKINSON’S DISEASES: Recent Developments
Edited by Israel Hanin, Mitsuo Yoshia, and Abraham Fisher
Volume 45 EPILEPSY AND THE CORPUS CALLOSUM 2
Edited by Alexander G. Reeves and David W. Roberts
Volume 46 BIOLOGY AND PHYSIOLOGY OFTHE BLOOD–BRAIN BARRIER:Transport, Cellular
Interactions, and Brain Pathologies
Edited by Pierre-Olivier Couraud and Daniel Scherman
Volume 47 THE BASAL GANGLIA V
Edited by Chihoto Ohye, Minoru Kimura, and John S. McKenzie
Volume 48 KINDLING 5
Edited by Michael E. Corcoran and Solomon Moshé
Volume 49 PROGRESS IN ALZHEIMER’S AND PARKINSON’S DISEASES
Edited by Abraham Fisher, Israel Hanin, and Mitsuo Yoshida
Volume 50 NEUROPSYCHOLOGY OF CHILDHOOD EPILEPSY
Edited by Isabelle Jambaqué, Maryse Lassonde, and Olivier Dulac
Volume 51 MAPPING THE PROGRESS OF ALZHEIMER’S AND PARKINSON’S DISEASE
Edited by Yoshikuni Mizuno, Abraham Fisher, and Israel Hanin
A Continuation Order Plan is available for this series. A continuation order will bring delivery of each new volume immediately
upon publication. Volumes are billed only upon actual shipment. For further information please contact the publisher.
MAPPING THE PROGRESS
OF ALZHEIMER’S AND
PARKINSON’S DISEASE
Edited by
Yoshikuni Mizuno
Juntendo University School of Medicine
Tokyo, Japan
Abraham Fisher
Israel Institute for Biological Research
Ness-Ziona, Israel
and
Israel Hanin
Stritch School of Medicine
Loyola University Chicago
Maywood, Illinois
KLUWER ACADEMIC PUBLISHERS
NEW YORK, BOSTON, DORDRECHT, LONDON, MOSCOW
eBookISBN: 0-306-47593-6
Print ISBN: 0-306-46763-1
©2002 Kluwer Academic Publishers
NewYork, Boston, Dordrecht, London, Moscow
Print ©2002 Kluwer Academic/Plenum Publishers
New York
All rights reserved
No part of this eBook maybe reproducedor transmitted inanyform or byanymeans,electronic,
mechanical, recording, or otherwise, without written consent from the Publisher
Created in the United States of America
Visit Kluwer Online at: http://kluweronline.com
and Kluwer's eBookstore at: http://ebooks.kluweronline.com
SCIENTIFIC ADVISORY BOARD
Konrad Beyreuther, Ph.D Ramon Cacabelos, Ph.D.
University of Heidelberg, Institute for CNS Disorders,
Heidelberg, Germany La Coruna, Spain
Donald B. Calne, M.D. Thomas N. Chase, M.D.
University of British Columbia, National Institute of Health,
Vancouver, Canada Bethesda, Maryland, USA
Mahlon R. DeLong. M.D. Stanley Fahn, M.D.
Emory University, ColumbiaUniversity,
Atlanta, Goeorgia, USA New York, New York, USA
Ezio Giacobini,M.D., Ph.D. Kazuo Hasegawa, M.D.
Universitaires de Geriatrie de Geneve, St. Marianna Medical School,
Geneva, Switzerland Kawasaki, Japan
Oleh Hornykiewicz, M.D. Yasuo Ihara, M.D.
University of Vienna, University of Tokyo,
Vienna, Austria Tokyo, Japan
Khalid Iqbal, Ph.D. Takeshi Iwatsubo, M.D.
New York State Institute for Basic Research, University of Tokyo,
Staten Island, New York, USA Tokyo, Japan
Peter Jenner, Ph.D. Ichiro Kanazawa, M.D.
Guy’s, King’s and St Thomas’ School of University of Tokyo,
Biomedical Sciences Tokyo, Japan
London, UK
V
VI SCIENTIFIC ADVISORY BOARD
Peter Kasa, M.D., Ph.D. Zaven S. Khachaturian, Ph.D.
Albert Szent-Gyorgyi Medical University, Ronald and Nancy Reagan Research
Somogyi. Hungary Institute, Potomac, Maryland, USA
William C. Koller, M.D. Tomoyoshi Kondo, M.D.
The University of Miami, Wakayama Medical College,
Miami, Florida, USA Wakayama, Japan
Amos D. Korczyn, M.D. Sadako Kuno, M.D.
Tel-Aviv University, National Utano Hospital,
Ramat-Aviv, Israel Kyoto, Japan
Anthony E. Lang, M.D. Virginia Lee, Ph.D.
Toronto Western Hospital, University of Pennsylvania,
Toronto, Canada Philadelphia,, USA
Abraham N. Lieberman, M.D. Eldad Melamed, M.D.
National Parkinson Foundation, Tel Aviv University,
Miami, Florida, USA Petah Tiqva, Israel
Dr. Daniel M. Michaelson, Ph.D. Dr. Toshitaka Nabeshima, Ph.D.
Tel-Aviv University, University of Nagoya,
Tel-Aviv, Israel Nagoya, Japan
Dr. Toshiharu Nagatsu, M.D., Ph.D. H. Narabayashi, M.D.
Fujita Health University, The Neurological Clinic,
Toyoake, Japan Tokyo, Japan
Roger M. Nitsch, M.D. Dr. Agneta Nordberg, Ph.D.
University of Zurich, Karolinska Institute,
Zurich, Switzerland Huddinge, Sweden
Wolfgang H. Oertel, M.D. C. Warren Olanow, M.D.
Philipps-University of Marburg, The Mount Sinai Medical Center,
Marburg, Germany New York, New York, USA
SCIENTIFIC ADVISORY BOARD VII
Dr. Elaine K. Perry, Ph.D Werner Poewe, M.D.
Newcastle General Hospital, University of Innsbruck,
Newcastle Upon Tyne, UK Innsbruck, Austria
Dr. Remi Quirion, Ph.D. Olivier Rascol, M.D.
Mcgill University, INSERM U455,
Verdun, Canada Toulouse, France
Dr. Dennis J. Selkoe, M.D. Dr. Peter H. St George-Hyslop, M.D., Ph.D.
Brigham & Women's Hospital, University of Toronto,
Boston, Massachusetts, USA Toronto, Canada
Dr. Gerald Stern, M.D. Fabrizio Stocchii, M.D.
The Middlessex Hospital, La Sapienza University
London, UK Roma Italy
Dr. Yoo-Hun Suh, M.D., Ph.D. Dr. Takeshi Tabira, M.D.
Seoul National University, National Center for Longevity Research
Seoul, Korea Ohbu, Japan
Masatoshi Takeda, M.D. Dr. Kunio Tashiro, M.D
Osaka University, University of Hokkaido,
Suita, Japan Sapporo, Japan
Dr. Eduardo Tolosa, M.D. Dr. John Q. Trojanowski, M.D., Ph.D
University of Balcelona, University of Pennsylvania,
Barcelona, Spain Philadelphia, Pensylvania, USA
Dr. Shoji Tsuji, M.D. Dr. Nobuo Yanagisawa, M.D., Ph.D.
Niigata University, National Chubu Hospital,
Niigata, Japan Ohbu, Japan
This page intentionally left blank
ACKNOWLEDGEMENTS
The Organizing Committee of the International Conference on Progress in Alzheimer’s
and Parkinson’s diseases gratefully acknowledges the support of the following
organizations:
Eli Lily Japan K.K.
Eisai Co., Ltd. & Pfizer Pharmaceuticals Inc.
Pharmacia Corporation
The Japanese Owners of Race Horses Association
Osaka Pharmaceutical Manufactures’ Association
The Pharmaceutical Manufacturers’ Association of Tokyo
Dr. Tairiku Amakusa
Dr. Banri Amakusa
Fujimoto Pharmaceutical Corp.
Kissei Pharmaceutical Co.
Kyowa Hakko Kogyo Co.
Medtronic Japan Co., Ltd.
National Parkinson Foundation
Nippon Boehringer Ingelheim Co.
Novartis
SumitomoPharmaceuticals
Dr. Taro Masaoka
Dr. Masahiro Nomoto
Dr. Masatoshi Morooka
Dr. Mitustoshi Yamamoto
Daiichi Radioisotope Labs., Ltd.
GlaxoSmithKline K.K.
Janssen-Kyowa Co., Ltd.
Meiji Seika Kaisha, Ltd.
ix